BioSpace News Archive

Blackstone Life Sciences has already invested and committed nearly $1 billion from this fund over the past three months, demonstrating strong demand for the strategy

The Alzheimer’s Foundation of America (AFA) is expanding the hours of its Helpline starting this Saturday, July 11 th . The new hours will be 9 am to 9 pm (ET) on weekdays and 9:00 am to 5:00 pm (ET) on weekends.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today the appointment of Georgia Garinois-Melenikiotou to the Board of Directors.

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary second quarter financial results.

Select Medical Holdings Corporation (“Select Medical”) (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2020 on Thursday, July 30, 2020 after the market closes.

Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease.

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced the pricing of its initial public offering of 14,000,000 shares of its common stock at a price to the public of $16.00 per share

Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced today the pricing of its primary and secondary public offering of 3,500,000 common shares of the Company, consisting of 2,000,000 common shares

PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that the Company has received its first shipment of 1000 bottles of its lemon hand sanitizer, described in previous Company news releases and designated Natural Product Number NPN 80099466 by Health Canada.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that Andrew Davis has been promoted to Chief Commercial Officer.